Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Rollover Study of Ixabepilone (BMS-247550) In Patients With Metastatic Breast Cancer Previously Treated With An Anthracycline And Who Are Taxane Resistant Who Have Completed Study CA163107 And Who Are Benefiting From Continuation On Therapy With Ixabepilone

NCT01027208 is registered in ClinicalTrials.gov with R-Pharm as lead sponsor.

NCT NCT01027208
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01027208 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Rollover Study of Ixabepilone (BMS-247550) In Patients With Metastatic Breast Cancer Previously Treated With An Anthracycline And Who Are Taxane Resistant Who Have Completed Study CA163107 And Who Are Benefiting From Continuation On Therapy With Ixabepilone
Lead sponsor
R-Pharm
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2006
Completion date
January 31, 2007
Enrollment
20 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic breast cancer